Related references
Note: Only part of the references are listed.Imaging the endocannabinoid signaling system
Barna Dudok et al.
JOURNAL OF NEUROSCIENCE METHODS (2022)
A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo
Ao Dong et al.
NATURE BIOTECHNOLOGY (2022)
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study
Kirsten R. Mueller-Vahl et al.
PHARMACOPSYCHIATRY (2022)
Endocannabinoid-Based Therapies
Daniele Piomelli et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder
Yu Kyung Lee et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
Mark E. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder
Eric C. Strain et al.
JAMA PSYCHIATRY (2021)
The changing opioid crisis: development, challenges and opportunities
Nora D. Volkow et al.
MOLECULAR PSYCHIATRY (2021)
Nonhuman animal models of substance use disorders: Translational value and utility to basic science
Mark A. Smith
DRUG AND ALCOHOL DEPENDENCE (2020)
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence
Vishakh Iyer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
Xiang-hu He et al.
ACTA PHARMACOLOGICA SINICA (2019)
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Matthew E. Sloan et al.
ACTA PHARMACOLOGICA SINICA (2019)
ABHD6: Its Place in Endocannabinoid Signaling and Beyond
Jessica K. Cao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Yann Chye et al.
FRONTIERS IN PSYCHIATRY (2019)
Stress, craving and mood as predictors of early dropout from opioid agonist therapy
Leigh Panlilio et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
THE NEUROSCIENCE OF DRUG REWARD AND ADDICTION
Nora D. Volkow et al.
PHYSIOLOGICAL REVIEWS (2019)
Understanding Addiction Using Animal Models
Brittany N. Kuhn et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
The neurobiology of addiction
George R. Uhl et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal
Ai-Ling Li et al.
MOLECULAR PHARMACOLOGY (2019)
Are Cocaine-Seeking Habits Necessary for the Development of Addiction-Like Behavior in Rats?
Bryan F. Singer et al.
JOURNAL OF NEUROSCIENCE (2018)
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
J. M. Wenzel et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Endocannabinoid system, stress and HPA axis
Vincenzo Micale et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Effects of Cannabinoid Type 2 Receptor Agonist AM1241 on Morphine-Induced Antinociception, Acute and Chronic Tolerance, and Dependence in Mice
Mingyue Zhang et al.
JOURNAL OF PAIN (2018)
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar et al.
PROGRESS IN LIPID RESEARCH (2018)
Role of the endocannabinoid system in drug addiction
Jorge Manzanares et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Factors associated with methadone maintenance therapy discontinuation among people who inject drugs
Ada Lo et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Beth Wiese et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Utility of Nonhuman Primates in Substance Use Disorders Research
Matthew L. Banks et al.
ILAR JOURNAL (2017)
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Shaness A. Grenald et al.
NEUROPHARMACOLOGY (2017)
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Matthew E. Sloan et al.
NEUROPHARMACOLOGY (2017)
Cannabinoid 1 receptor blockade in the dorsal hippocampus prevents the reinstatement but not acquisition of morphine-induced conditioned place preference in rats
Xin Zhao et al.
NEUROREPORT (2017)
Differential expression of endocannabinoid system-related genes in the dorsal hippocampus following expression and reinstatement of morphine conditioned place preference in mice
Wei Li et al.
NEUROSCIENCE LETTERS (2017)
Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
Mauro Maccarrone
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats
Mingyue Zhang et al.
ANESTHESIA AND ANALGESIA (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Aliou B. Gueye et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Targeting the Endocannabinoid System in Psychiatric Illness
Martin A. Katzman et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens
Marzieh Molaei et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus
Jianbo Zhang et al.
NEUROSCIENCE LETTERS (2016)
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Kyle Kampman et al.
JOURNAL OF ADDICTION MEDICINE (2015)
Endocannabinoid signalling in reward and addiction
Loren H. Parsons et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Circuitry of self-control and its role in reducing addiction
Yi-Yuan Tang et al.
TRENDS IN COGNITIVE SCIENCES (2015)
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
Hai-Ying Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Yih-Ing Hser et al.
ADDICTION (2014)
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats
Kiri L. Wills et al.
PSYCHOPHARMACOLOGY (2014)
The Design of a Quantitative Western Blot Experiment
Sean C. Taylor et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal
Wei-Xin Yuan et al.
BRAIN RESEARCH (2013)
Perceived stress and substance use in methadone-maintained smokers
Ethan Moitra et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered wanting' for reward: entire core and medial shell mapped as substrates for PIT enhancement
Susana Pecina et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Cannabinoid Transmission in the Prelimbic Cortex Bidirectionally Controls Opiate Reward and Aversion Signaling through Dissociable Kappa Versus μ-Opiate Receptor Dependent Mechanisms
Tasha Ahmad et al.
JOURNAL OF NEUROSCIENCE (2013)
DYSREGULATION OF CANNABINOID CB1 RECEPTOR AND ASSOCIATED SIGNALING NETWORKS IN BRAINS OF COCAINE ADDICTS AND COCAINE-TREATED RODENTS
M. Alvaro-Bartolome et al.
NEUROSCIENCE (2013)
CANNABINOID AND OPIOID INTERACTIONS: IMPLICATIONS FOR OPIATE DEPENDENCE AND WITHDRAWAL
J. L. Scavone et al.
NEUROSCIENCE (2013)
What's conditioned in conditioned place preference?
Joseph P. Huston et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Exposure to morphine affects the expression of endocannabinoid receptors and immune functions
Qing-Yu Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: A comprehensive review from an analytical and biological perspective
Alexander A. Zoerner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2011)
A Randomized, Controlled Study to Investigate the Analgesic Efficacy of Single Doses of the Cannabinoid Receptor-2 Agonist GW842166, Ibuprofen or Placebo in Patients With Acute Pain Following Third Molar Tooth Extraction
Thor Ostenfeld et al.
CLINICAL JOURNAL OF PAIN (2011)
Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice
Divya Ramesh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Systematic review of prospective studies investigating remission from amphetamine, cannabis, cocaine or opioid dependence
Bianca Calabria et al.
ADDICTIVE BEHAVIORS (2010)
Insight Into the Relationship Between Impulsivity and Substance Abuse From Studies Using Animal Models
Catharine A. Winstanley et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Comparison of hybridization methods and real-time PCR: their value in animal cell line characterization
Helga Boehm-Hofstaetter et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors
Jillian L. Scavone et al.
BRAIN RESEARCH (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Functional Interactions between Endogenous Cannabinoid and Opioid Systems: Focus on Alcohol, Genetics and Drug-Addicted Behaviors
J. A. Lopez-Moreno et al.
CURRENT DRUG TARGETS (2010)
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006
Bohdan Nosyk et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
Emmanuel S. Onaivi et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Chronic Stress, Drug Use, and Vulnerability to Addiction
Rajita Sinha
ADDICTION REVIEWS 2008 (2008)
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases
Diego Centonze et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
Minoru Hojo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Mauro Maccarrone et al.
NATURE NEUROSCIENCE (2008)
Microdialysis and the neurochemistry of addiction
Mary M. Torregrossa et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
J. M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration
Stephanie Caille et al.
JOURNAL OF NEUROSCIENCE (2007)
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2
Liana Fattore et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation
Joseph F. Cheer et al.
JOURNAL OF NEUROSCIENCE (2007)
Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core
A. N. M. Schoffelmeer et al.
NEUROPHARMACOLOGY (2006)
Molecular and cellular basis of cannabinoid and opioid interactions
D Viganò et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine
D Viganò et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The [35S]GTPγS binding assay:: approaches and applications in pharmacology
C Harrison et al.
LIFE SCIENCES (2003)
SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats
S Caillé et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats
TJ De Vries et al.
PSYCHOPHARMACOLOGY (2003)
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain
D Viganò et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats
S González et al.
ADDICTION BIOLOGY (2003)
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404
I Del Arco et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels
S Gonzalez et al.
DRUG AND ALCOHOL DEPENDENCE (2002)
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes
JR Savinainen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins:: reduction in morphine withdrawal syndrome without change in rewarding effect
O Valverde et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Ultrastructural localization of the CB1 cannabinoid receptor in μ-opioid receptor patches of the rat caudate putamen nucleus
JJ Rodríguez et al.
JOURNAL OF NEUROSCIENCE (2001)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain
LJ Sim-Selley et al.
JOURNAL OF NEUROSCIENCE (2000)
Proteomic analysis
MJ Dutt et al.
CURRENT OPINION IN BIOTECHNOLOGY (2000)
Share Paper
